Replies to post #59615 on Biotech Values

[masterlongevity]

where do you think those #s will be at the end of 08?

my guess...
Copaxone 25%
Avonex 24%
Rebif 22
Betason 19
Tysabri 10

[DewDiligence]

Where new US Tysabri patients came from (1H08):



Source: Biogen Idec


Let’s talk biotech!
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”